50 Studies Every Urologist Should Know
Herausgeber: Dahm, Philipp
Schade – dieser Artikel ist leider ausverkauft. Sobald wir wissen, ob und wann der Artikel wieder verfügbar ist, informieren wir Sie an dieser Stelle.
50 Studies Every Urologist Should Know
Herausgeber: Dahm, Philipp
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
50 Studies Every Urologist Should Know presents key studies that have shaped the practice of urology. For each study, a concise summary is presented with an emphasis on the results and limitations of the study, and its implications for practice. An illustrative clinical case concludes each review, followed by brief information on other relevant studies. This book is a must-read for healthcare professionals in urology, as well as anyone who wants to learn more about the data behind clinical practice.
50 Studies Every Urologist Should Know presents key studies that have shaped the practice of urology. For each study, a concise summary is presented with an emphasis on the results and limitations of the study, and its implications for practice. An illustrative clinical case concludes each review, followed by brief information on other relevant studies. This book is a must-read for healthcare professionals in urology, as well as anyone who wants to learn more about the data behind clinical practice.
Produktdetails
- Produktdetails
- Verlag: Oxford University Press, USA
- Seitenzahl: 320
- Erscheinungstermin: 12. März 2021
- Englisch
- Abmessung: 231mm x 155mm x 20mm
- Gewicht: 476g
- ISBN-13: 9780190655341
- ISBN-10: 0190655348
- Artikelnr.: 60981208
- Verlag: Oxford University Press, USA
- Seitenzahl: 320
- Erscheinungstermin: 12. März 2021
- Englisch
- Abmessung: 231mm x 155mm x 20mm
- Gewicht: 476g
- ISBN-13: 9780190655341
- ISBN-10: 0190655348
- Artikelnr.: 60981208
Philipp Dahm is currently Professor of Urology at the University of Minnesota and Director of Research and Education for Surgical Services at the Minneapolis Veterans Administration Health Care System. Dr. Dahm completed his residency training at Duke University in Durham, North Carolina where he subsequently joined the faculty and completed a Master of Health Sciences in Clinical Research. From 2006 - 2014 he was Associate and then Full Professor in the Department of Urology at the University of Florida (UF) in Gainesville, Florida, as well as in the later years, Residency Program Director.
* Chapter 1: Radical prostatectomy versus observation for localized
prostate cancer: The European Randomized Study of Screening for
Prostate Cancer (ERSPC)
* Chapter 2: The Influence of Finasteride on the Development of
Prostate Cancer: Prostate Cancer Prevention Trial (PCPT)1
* Chapter 3: MRI-Targeted or Standard Biopsy for Prostate Cancer
Diagnosis: The PRECISION Trial
* Chapter 4: Long-term survival among men with conservatively treated
localized prostate cancer: Conservative management of prostate
cancer-watchful waiting
* Chapter 5: Clinical results of long-term follow-up of a large, active
surveillance cohort with localized prostate cancer
* Chapter 6: Radical prostatectomy versus Observation in Early Prostate
Cancer: Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4)
* Chapter 7: Radical prostatectomy versus observation for localized
prostate cancer: The PIVOT Trial
* Chapter 8: 10-Year Outcomes after Monitoring, Surgery, or
Radiotherapy: The Prostate Testing for Cancer and Treatment (ProtecT)
trial
* Chapter 9: Comparative Effectiveness of Minimally Invasive vs Open
Radical Prostatectomy
* Chapter 10: Quality of life and satisfaction with outcome among
prostate-cancer survivors: Quality of life after primary treatment of
localized prostate cancer
* Chapter 11: Adjuvant Radiotherapy for Pathologically Advanced
Prostate Cancer: A Randomized Clinical Trial: The Southwest Oncology
Group 8794 Trial
* Chapter 12: Survival Following Primary Androgen Deprivation Therapy
Among Men with Localized Prostate Cancer
* Chapter 13: Bilateral Orchiectomy with or without Flutamide for
Metastatic Prostate Cancer
* Chapter 14: Intermittent versus Continuous Androgen Deprivation in
Prostate Cancer: Intermittent androgen deprivation therapy (SWOG
Trial 9346)
* Chapter 15: Docetaxel plus Prednisone or Mitoxantrone plus Prednisone
for Advanced Prostate Cancer: The TAX 327 Trial
* Chapter 16: Chemohormonal Therapy in Metastatic Hormone-Sensitive
Prostate Cancer
* Chapter 17: Abiraterone and Increased Survival in Metastatic Prostate
Cancer
* Chapter 18: Enzalutamide in Metastatic Prostate Cancer before
Chemotherapy: The PREVAIL Study
* Chapter 19: The EORTC Intergroup Phase 3 Study Comparing the
Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical
Nephrectomy for Low-Stage Renal Cell Carcinoma
* Chapter 20: Nephrectomy Followed by Interferon Alfa-2b Compared With
Interferon Alfa-2b Alone For Metastatic Renal-Cell Cancer
* Chapter 21: Sunitinib versus Interferon Alfa in Metastatic Renal-Cell
Carcinoma
* Chapter 22: Nivolumab versus Everolimus in Advanced Renal-Cell
Carcinoma: CheckMate 025
* Chapter 23: The Effect of Intravesical Mitomycin C on Recurrence of
Newly Diagnosed Superficial Bladder Cancer: A Further Report with 7
Years of Follow-Up
* Chapter 24: Bacillus Calmette-Guerin (BCG) Immunotherapy for
Recurrent Non-Invasive Transitional Cell Carcinoma of the Bladder: A
Randomized Southwest Oncology Group Study
* Chapter 25: Neoadjuvant Chemotherapy plus Cystectomy Compared with
Cystectomy Alone for Locally Advanced Bladder Cancer
* Chapter 26: Radiotherapy with or without Chemotherapy in
Muscle-Invasive Bladder Cancer
* Chapter 27: A Randomized Comparison of Cisplatin Alone or in
Combination with Methotrexate, Vinblastine, and Doxorubicin in
Patients with Metastatic Urothelial Carcinoma: A Cooperative Group
Study
* Chapter 28: Gemcitabine and cisplatin versus methotrexate,
vinblastine, doxorubicin, and cisplatin in advanced or metastatic
bladder cancer: results of a large, randomized, multinational,
multicenter, phase III study
* Chapter 29: Pembrolizumab as Second-Line Therapy for Advanced
Urothelial Carcinoma: KEYNOTE-045
* Chapter 30: Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin
Combination Chemotherapy in Disseminated Testicular Cancer
* Chapter 31: Treatment of Disseminated Germ-Cell Tumors with
Cisplatin, Bleomycin, and either Vinblastine or Etoposide: PVB versus
BEP
* Chapter 32: Urinary Volume, Water and Stones Recurrence in Idiopathic
Calcium Nephrolithiasis: a 5-Year Randomized Prospective Study
* Chapter 33: A Prospective Study of Dietary Calcium and Other
Nutrients and the Risk of Symptomatic Kidney Stones
* Chapter 34: First Clinical Experience with Extracorporeally Induced
Destruction of Kidney Stones by Shock Waves
* Chapter 35: Shockwave lithotripsy versus ureteroscopy for lower pole
caliceal calculi 1 cm or less
* Chapter 36: Extracorporeal shockwave lithotripsy versus percutaneous
nephrolithotomy for lower pole nephrolithiasis: The Lower Pole I
Study
* Chapter 37: Medical Expulsive Therapy in Adults with Ureteric Colic:
The SUSPEND Trial
* Chapter 38: Burch Colposuspension versus Fascial Sling to Reduce
Urinary Stress Incontinence: The Stress Incontinence Surgical
Treatment Efficacy (SISTEr) Trial
* Chapter 39: Retropubic versus Transobturator Midurethral Slings for
Stress Incontinence: The Trial of Mid Urethral Slings (TOMUS)
* Chapter 40: A midurethral sling to reduce incontinence after vaginal
prolapse repair: The Outcomes Following Vaginal Prolapse Repair and
Midurethral Sling (OPUS) trial
* Chapter 41: A Randomized Trial of Urodynamic Testing Before Stress
Incontinence Surgery: The VALUE Study
* Chapter 42: Anticholinergic Therapy versus Onabotulinumtoxin A for
Urgency Urinary Incontinence: The Anticholinergic versus Botulinum
Toxin Comparison-ABC-study
* Chapter 43: Oral sildenafil in the treatment of erectile dysfunction
* Chapter 44: Treatment of men with erectile dysfunction with
transurethral alprostadil
* Chapter 45: Antimicrobial Prophylaxis for Children with
Vesicoureteral Reflux: Randomized Intervention for Children with
Vesicoureteral Reflux (RIVUR) trial
* Chapter 46: A Comparison of Transurethral Surgery with Watchful
Waiting for Moderate Symptoms of Benign Prostatic Hyperplasia: The
Veterans Affairs Cooperative Study Group on Transurethral Resection
of the Prostate
* Chapter 47: The Efficacy of Terazosin, Finasteride, or both in Benign
Prostatic Hyperplasia: The Veterans Affairs Cooperative Benign
Prostatic Hyperplasia Study
* Chapter 48: Chlorhexidine-Alcohol versus Povidone- Iodine for
Surgical-Site Antisepsis
* Chapter 49: Clean, Intermittent Self-Catheterization in the Treatment
of Urinary Tract Disease
* Chapter 50: The Surgical Learning Curve for Prostate Cancer Control
after Radical Prostatectomy
prostate cancer: The European Randomized Study of Screening for
Prostate Cancer (ERSPC)
* Chapter 2: The Influence of Finasteride on the Development of
Prostate Cancer: Prostate Cancer Prevention Trial (PCPT)1
* Chapter 3: MRI-Targeted or Standard Biopsy for Prostate Cancer
Diagnosis: The PRECISION Trial
* Chapter 4: Long-term survival among men with conservatively treated
localized prostate cancer: Conservative management of prostate
cancer-watchful waiting
* Chapter 5: Clinical results of long-term follow-up of a large, active
surveillance cohort with localized prostate cancer
* Chapter 6: Radical prostatectomy versus Observation in Early Prostate
Cancer: Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4)
* Chapter 7: Radical prostatectomy versus observation for localized
prostate cancer: The PIVOT Trial
* Chapter 8: 10-Year Outcomes after Monitoring, Surgery, or
Radiotherapy: The Prostate Testing for Cancer and Treatment (ProtecT)
trial
* Chapter 9: Comparative Effectiveness of Minimally Invasive vs Open
Radical Prostatectomy
* Chapter 10: Quality of life and satisfaction with outcome among
prostate-cancer survivors: Quality of life after primary treatment of
localized prostate cancer
* Chapter 11: Adjuvant Radiotherapy for Pathologically Advanced
Prostate Cancer: A Randomized Clinical Trial: The Southwest Oncology
Group 8794 Trial
* Chapter 12: Survival Following Primary Androgen Deprivation Therapy
Among Men with Localized Prostate Cancer
* Chapter 13: Bilateral Orchiectomy with or without Flutamide for
Metastatic Prostate Cancer
* Chapter 14: Intermittent versus Continuous Androgen Deprivation in
Prostate Cancer: Intermittent androgen deprivation therapy (SWOG
Trial 9346)
* Chapter 15: Docetaxel plus Prednisone or Mitoxantrone plus Prednisone
for Advanced Prostate Cancer: The TAX 327 Trial
* Chapter 16: Chemohormonal Therapy in Metastatic Hormone-Sensitive
Prostate Cancer
* Chapter 17: Abiraterone and Increased Survival in Metastatic Prostate
Cancer
* Chapter 18: Enzalutamide in Metastatic Prostate Cancer before
Chemotherapy: The PREVAIL Study
* Chapter 19: The EORTC Intergroup Phase 3 Study Comparing the
Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical
Nephrectomy for Low-Stage Renal Cell Carcinoma
* Chapter 20: Nephrectomy Followed by Interferon Alfa-2b Compared With
Interferon Alfa-2b Alone For Metastatic Renal-Cell Cancer
* Chapter 21: Sunitinib versus Interferon Alfa in Metastatic Renal-Cell
Carcinoma
* Chapter 22: Nivolumab versus Everolimus in Advanced Renal-Cell
Carcinoma: CheckMate 025
* Chapter 23: The Effect of Intravesical Mitomycin C on Recurrence of
Newly Diagnosed Superficial Bladder Cancer: A Further Report with 7
Years of Follow-Up
* Chapter 24: Bacillus Calmette-Guerin (BCG) Immunotherapy for
Recurrent Non-Invasive Transitional Cell Carcinoma of the Bladder: A
Randomized Southwest Oncology Group Study
* Chapter 25: Neoadjuvant Chemotherapy plus Cystectomy Compared with
Cystectomy Alone for Locally Advanced Bladder Cancer
* Chapter 26: Radiotherapy with or without Chemotherapy in
Muscle-Invasive Bladder Cancer
* Chapter 27: A Randomized Comparison of Cisplatin Alone or in
Combination with Methotrexate, Vinblastine, and Doxorubicin in
Patients with Metastatic Urothelial Carcinoma: A Cooperative Group
Study
* Chapter 28: Gemcitabine and cisplatin versus methotrexate,
vinblastine, doxorubicin, and cisplatin in advanced or metastatic
bladder cancer: results of a large, randomized, multinational,
multicenter, phase III study
* Chapter 29: Pembrolizumab as Second-Line Therapy for Advanced
Urothelial Carcinoma: KEYNOTE-045
* Chapter 30: Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin
Combination Chemotherapy in Disseminated Testicular Cancer
* Chapter 31: Treatment of Disseminated Germ-Cell Tumors with
Cisplatin, Bleomycin, and either Vinblastine or Etoposide: PVB versus
BEP
* Chapter 32: Urinary Volume, Water and Stones Recurrence in Idiopathic
Calcium Nephrolithiasis: a 5-Year Randomized Prospective Study
* Chapter 33: A Prospective Study of Dietary Calcium and Other
Nutrients and the Risk of Symptomatic Kidney Stones
* Chapter 34: First Clinical Experience with Extracorporeally Induced
Destruction of Kidney Stones by Shock Waves
* Chapter 35: Shockwave lithotripsy versus ureteroscopy for lower pole
caliceal calculi 1 cm or less
* Chapter 36: Extracorporeal shockwave lithotripsy versus percutaneous
nephrolithotomy for lower pole nephrolithiasis: The Lower Pole I
Study
* Chapter 37: Medical Expulsive Therapy in Adults with Ureteric Colic:
The SUSPEND Trial
* Chapter 38: Burch Colposuspension versus Fascial Sling to Reduce
Urinary Stress Incontinence: The Stress Incontinence Surgical
Treatment Efficacy (SISTEr) Trial
* Chapter 39: Retropubic versus Transobturator Midurethral Slings for
Stress Incontinence: The Trial of Mid Urethral Slings (TOMUS)
* Chapter 40: A midurethral sling to reduce incontinence after vaginal
prolapse repair: The Outcomes Following Vaginal Prolapse Repair and
Midurethral Sling (OPUS) trial
* Chapter 41: A Randomized Trial of Urodynamic Testing Before Stress
Incontinence Surgery: The VALUE Study
* Chapter 42: Anticholinergic Therapy versus Onabotulinumtoxin A for
Urgency Urinary Incontinence: The Anticholinergic versus Botulinum
Toxin Comparison-ABC-study
* Chapter 43: Oral sildenafil in the treatment of erectile dysfunction
* Chapter 44: Treatment of men with erectile dysfunction with
transurethral alprostadil
* Chapter 45: Antimicrobial Prophylaxis for Children with
Vesicoureteral Reflux: Randomized Intervention for Children with
Vesicoureteral Reflux (RIVUR) trial
* Chapter 46: A Comparison of Transurethral Surgery with Watchful
Waiting for Moderate Symptoms of Benign Prostatic Hyperplasia: The
Veterans Affairs Cooperative Study Group on Transurethral Resection
of the Prostate
* Chapter 47: The Efficacy of Terazosin, Finasteride, or both in Benign
Prostatic Hyperplasia: The Veterans Affairs Cooperative Benign
Prostatic Hyperplasia Study
* Chapter 48: Chlorhexidine-Alcohol versus Povidone- Iodine for
Surgical-Site Antisepsis
* Chapter 49: Clean, Intermittent Self-Catheterization in the Treatment
of Urinary Tract Disease
* Chapter 50: The Surgical Learning Curve for Prostate Cancer Control
after Radical Prostatectomy
* Chapter 1: Radical prostatectomy versus observation for localized
prostate cancer: The European Randomized Study of Screening for
Prostate Cancer (ERSPC)
* Chapter 2: The Influence of Finasteride on the Development of
Prostate Cancer: Prostate Cancer Prevention Trial (PCPT)1
* Chapter 3: MRI-Targeted or Standard Biopsy for Prostate Cancer
Diagnosis: The PRECISION Trial
* Chapter 4: Long-term survival among men with conservatively treated
localized prostate cancer: Conservative management of prostate
cancer-watchful waiting
* Chapter 5: Clinical results of long-term follow-up of a large, active
surveillance cohort with localized prostate cancer
* Chapter 6: Radical prostatectomy versus Observation in Early Prostate
Cancer: Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4)
* Chapter 7: Radical prostatectomy versus observation for localized
prostate cancer: The PIVOT Trial
* Chapter 8: 10-Year Outcomes after Monitoring, Surgery, or
Radiotherapy: The Prostate Testing for Cancer and Treatment (ProtecT)
trial
* Chapter 9: Comparative Effectiveness of Minimally Invasive vs Open
Radical Prostatectomy
* Chapter 10: Quality of life and satisfaction with outcome among
prostate-cancer survivors: Quality of life after primary treatment of
localized prostate cancer
* Chapter 11: Adjuvant Radiotherapy for Pathologically Advanced
Prostate Cancer: A Randomized Clinical Trial: The Southwest Oncology
Group 8794 Trial
* Chapter 12: Survival Following Primary Androgen Deprivation Therapy
Among Men with Localized Prostate Cancer
* Chapter 13: Bilateral Orchiectomy with or without Flutamide for
Metastatic Prostate Cancer
* Chapter 14: Intermittent versus Continuous Androgen Deprivation in
Prostate Cancer: Intermittent androgen deprivation therapy (SWOG
Trial 9346)
* Chapter 15: Docetaxel plus Prednisone or Mitoxantrone plus Prednisone
for Advanced Prostate Cancer: The TAX 327 Trial
* Chapter 16: Chemohormonal Therapy in Metastatic Hormone-Sensitive
Prostate Cancer
* Chapter 17: Abiraterone and Increased Survival in Metastatic Prostate
Cancer
* Chapter 18: Enzalutamide in Metastatic Prostate Cancer before
Chemotherapy: The PREVAIL Study
* Chapter 19: The EORTC Intergroup Phase 3 Study Comparing the
Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical
Nephrectomy for Low-Stage Renal Cell Carcinoma
* Chapter 20: Nephrectomy Followed by Interferon Alfa-2b Compared With
Interferon Alfa-2b Alone For Metastatic Renal-Cell Cancer
* Chapter 21: Sunitinib versus Interferon Alfa in Metastatic Renal-Cell
Carcinoma
* Chapter 22: Nivolumab versus Everolimus in Advanced Renal-Cell
Carcinoma: CheckMate 025
* Chapter 23: The Effect of Intravesical Mitomycin C on Recurrence of
Newly Diagnosed Superficial Bladder Cancer: A Further Report with 7
Years of Follow-Up
* Chapter 24: Bacillus Calmette-Guerin (BCG) Immunotherapy for
Recurrent Non-Invasive Transitional Cell Carcinoma of the Bladder: A
Randomized Southwest Oncology Group Study
* Chapter 25: Neoadjuvant Chemotherapy plus Cystectomy Compared with
Cystectomy Alone for Locally Advanced Bladder Cancer
* Chapter 26: Radiotherapy with or without Chemotherapy in
Muscle-Invasive Bladder Cancer
* Chapter 27: A Randomized Comparison of Cisplatin Alone or in
Combination with Methotrexate, Vinblastine, and Doxorubicin in
Patients with Metastatic Urothelial Carcinoma: A Cooperative Group
Study
* Chapter 28: Gemcitabine and cisplatin versus methotrexate,
vinblastine, doxorubicin, and cisplatin in advanced or metastatic
bladder cancer: results of a large, randomized, multinational,
multicenter, phase III study
* Chapter 29: Pembrolizumab as Second-Line Therapy for Advanced
Urothelial Carcinoma: KEYNOTE-045
* Chapter 30: Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin
Combination Chemotherapy in Disseminated Testicular Cancer
* Chapter 31: Treatment of Disseminated Germ-Cell Tumors with
Cisplatin, Bleomycin, and either Vinblastine or Etoposide: PVB versus
BEP
* Chapter 32: Urinary Volume, Water and Stones Recurrence in Idiopathic
Calcium Nephrolithiasis: a 5-Year Randomized Prospective Study
* Chapter 33: A Prospective Study of Dietary Calcium and Other
Nutrients and the Risk of Symptomatic Kidney Stones
* Chapter 34: First Clinical Experience with Extracorporeally Induced
Destruction of Kidney Stones by Shock Waves
* Chapter 35: Shockwave lithotripsy versus ureteroscopy for lower pole
caliceal calculi 1 cm or less
* Chapter 36: Extracorporeal shockwave lithotripsy versus percutaneous
nephrolithotomy for lower pole nephrolithiasis: The Lower Pole I
Study
* Chapter 37: Medical Expulsive Therapy in Adults with Ureteric Colic:
The SUSPEND Trial
* Chapter 38: Burch Colposuspension versus Fascial Sling to Reduce
Urinary Stress Incontinence: The Stress Incontinence Surgical
Treatment Efficacy (SISTEr) Trial
* Chapter 39: Retropubic versus Transobturator Midurethral Slings for
Stress Incontinence: The Trial of Mid Urethral Slings (TOMUS)
* Chapter 40: A midurethral sling to reduce incontinence after vaginal
prolapse repair: The Outcomes Following Vaginal Prolapse Repair and
Midurethral Sling (OPUS) trial
* Chapter 41: A Randomized Trial of Urodynamic Testing Before Stress
Incontinence Surgery: The VALUE Study
* Chapter 42: Anticholinergic Therapy versus Onabotulinumtoxin A for
Urgency Urinary Incontinence: The Anticholinergic versus Botulinum
Toxin Comparison-ABC-study
* Chapter 43: Oral sildenafil in the treatment of erectile dysfunction
* Chapter 44: Treatment of men with erectile dysfunction with
transurethral alprostadil
* Chapter 45: Antimicrobial Prophylaxis for Children with
Vesicoureteral Reflux: Randomized Intervention for Children with
Vesicoureteral Reflux (RIVUR) trial
* Chapter 46: A Comparison of Transurethral Surgery with Watchful
Waiting for Moderate Symptoms of Benign Prostatic Hyperplasia: The
Veterans Affairs Cooperative Study Group on Transurethral Resection
of the Prostate
* Chapter 47: The Efficacy of Terazosin, Finasteride, or both in Benign
Prostatic Hyperplasia: The Veterans Affairs Cooperative Benign
Prostatic Hyperplasia Study
* Chapter 48: Chlorhexidine-Alcohol versus Povidone- Iodine for
Surgical-Site Antisepsis
* Chapter 49: Clean, Intermittent Self-Catheterization in the Treatment
of Urinary Tract Disease
* Chapter 50: The Surgical Learning Curve for Prostate Cancer Control
after Radical Prostatectomy
prostate cancer: The European Randomized Study of Screening for
Prostate Cancer (ERSPC)
* Chapter 2: The Influence of Finasteride on the Development of
Prostate Cancer: Prostate Cancer Prevention Trial (PCPT)1
* Chapter 3: MRI-Targeted or Standard Biopsy for Prostate Cancer
Diagnosis: The PRECISION Trial
* Chapter 4: Long-term survival among men with conservatively treated
localized prostate cancer: Conservative management of prostate
cancer-watchful waiting
* Chapter 5: Clinical results of long-term follow-up of a large, active
surveillance cohort with localized prostate cancer
* Chapter 6: Radical prostatectomy versus Observation in Early Prostate
Cancer: Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4)
* Chapter 7: Radical prostatectomy versus observation for localized
prostate cancer: The PIVOT Trial
* Chapter 8: 10-Year Outcomes after Monitoring, Surgery, or
Radiotherapy: The Prostate Testing for Cancer and Treatment (ProtecT)
trial
* Chapter 9: Comparative Effectiveness of Minimally Invasive vs Open
Radical Prostatectomy
* Chapter 10: Quality of life and satisfaction with outcome among
prostate-cancer survivors: Quality of life after primary treatment of
localized prostate cancer
* Chapter 11: Adjuvant Radiotherapy for Pathologically Advanced
Prostate Cancer: A Randomized Clinical Trial: The Southwest Oncology
Group 8794 Trial
* Chapter 12: Survival Following Primary Androgen Deprivation Therapy
Among Men with Localized Prostate Cancer
* Chapter 13: Bilateral Orchiectomy with or without Flutamide for
Metastatic Prostate Cancer
* Chapter 14: Intermittent versus Continuous Androgen Deprivation in
Prostate Cancer: Intermittent androgen deprivation therapy (SWOG
Trial 9346)
* Chapter 15: Docetaxel plus Prednisone or Mitoxantrone plus Prednisone
for Advanced Prostate Cancer: The TAX 327 Trial
* Chapter 16: Chemohormonal Therapy in Metastatic Hormone-Sensitive
Prostate Cancer
* Chapter 17: Abiraterone and Increased Survival in Metastatic Prostate
Cancer
* Chapter 18: Enzalutamide in Metastatic Prostate Cancer before
Chemotherapy: The PREVAIL Study
* Chapter 19: The EORTC Intergroup Phase 3 Study Comparing the
Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical
Nephrectomy for Low-Stage Renal Cell Carcinoma
* Chapter 20: Nephrectomy Followed by Interferon Alfa-2b Compared With
Interferon Alfa-2b Alone For Metastatic Renal-Cell Cancer
* Chapter 21: Sunitinib versus Interferon Alfa in Metastatic Renal-Cell
Carcinoma
* Chapter 22: Nivolumab versus Everolimus in Advanced Renal-Cell
Carcinoma: CheckMate 025
* Chapter 23: The Effect of Intravesical Mitomycin C on Recurrence of
Newly Diagnosed Superficial Bladder Cancer: A Further Report with 7
Years of Follow-Up
* Chapter 24: Bacillus Calmette-Guerin (BCG) Immunotherapy for
Recurrent Non-Invasive Transitional Cell Carcinoma of the Bladder: A
Randomized Southwest Oncology Group Study
* Chapter 25: Neoadjuvant Chemotherapy plus Cystectomy Compared with
Cystectomy Alone for Locally Advanced Bladder Cancer
* Chapter 26: Radiotherapy with or without Chemotherapy in
Muscle-Invasive Bladder Cancer
* Chapter 27: A Randomized Comparison of Cisplatin Alone or in
Combination with Methotrexate, Vinblastine, and Doxorubicin in
Patients with Metastatic Urothelial Carcinoma: A Cooperative Group
Study
* Chapter 28: Gemcitabine and cisplatin versus methotrexate,
vinblastine, doxorubicin, and cisplatin in advanced or metastatic
bladder cancer: results of a large, randomized, multinational,
multicenter, phase III study
* Chapter 29: Pembrolizumab as Second-Line Therapy for Advanced
Urothelial Carcinoma: KEYNOTE-045
* Chapter 30: Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin
Combination Chemotherapy in Disseminated Testicular Cancer
* Chapter 31: Treatment of Disseminated Germ-Cell Tumors with
Cisplatin, Bleomycin, and either Vinblastine or Etoposide: PVB versus
BEP
* Chapter 32: Urinary Volume, Water and Stones Recurrence in Idiopathic
Calcium Nephrolithiasis: a 5-Year Randomized Prospective Study
* Chapter 33: A Prospective Study of Dietary Calcium and Other
Nutrients and the Risk of Symptomatic Kidney Stones
* Chapter 34: First Clinical Experience with Extracorporeally Induced
Destruction of Kidney Stones by Shock Waves
* Chapter 35: Shockwave lithotripsy versus ureteroscopy for lower pole
caliceal calculi 1 cm or less
* Chapter 36: Extracorporeal shockwave lithotripsy versus percutaneous
nephrolithotomy for lower pole nephrolithiasis: The Lower Pole I
Study
* Chapter 37: Medical Expulsive Therapy in Adults with Ureteric Colic:
The SUSPEND Trial
* Chapter 38: Burch Colposuspension versus Fascial Sling to Reduce
Urinary Stress Incontinence: The Stress Incontinence Surgical
Treatment Efficacy (SISTEr) Trial
* Chapter 39: Retropubic versus Transobturator Midurethral Slings for
Stress Incontinence: The Trial of Mid Urethral Slings (TOMUS)
* Chapter 40: A midurethral sling to reduce incontinence after vaginal
prolapse repair: The Outcomes Following Vaginal Prolapse Repair and
Midurethral Sling (OPUS) trial
* Chapter 41: A Randomized Trial of Urodynamic Testing Before Stress
Incontinence Surgery: The VALUE Study
* Chapter 42: Anticholinergic Therapy versus Onabotulinumtoxin A for
Urgency Urinary Incontinence: The Anticholinergic versus Botulinum
Toxin Comparison-ABC-study
* Chapter 43: Oral sildenafil in the treatment of erectile dysfunction
* Chapter 44: Treatment of men with erectile dysfunction with
transurethral alprostadil
* Chapter 45: Antimicrobial Prophylaxis for Children with
Vesicoureteral Reflux: Randomized Intervention for Children with
Vesicoureteral Reflux (RIVUR) trial
* Chapter 46: A Comparison of Transurethral Surgery with Watchful
Waiting for Moderate Symptoms of Benign Prostatic Hyperplasia: The
Veterans Affairs Cooperative Study Group on Transurethral Resection
of the Prostate
* Chapter 47: The Efficacy of Terazosin, Finasteride, or both in Benign
Prostatic Hyperplasia: The Veterans Affairs Cooperative Benign
Prostatic Hyperplasia Study
* Chapter 48: Chlorhexidine-Alcohol versus Povidone- Iodine for
Surgical-Site Antisepsis
* Chapter 49: Clean, Intermittent Self-Catheterization in the Treatment
of Urinary Tract Disease
* Chapter 50: The Surgical Learning Curve for Prostate Cancer Control
after Radical Prostatectomy